Table 1.
Strategy | Phage (carrier) | Vector (target) | Epitope/mimotope/gene | Vaccination | Results | Ref. |
Display of immunogens on phage particles | T7 (10B) | T7 Select 415-B | “a” determinant of HBsAg (residues 111-156) | Rabbit (subcutaneous) Freund’s complete adjuvant | Anti-HBsAg antibody induced | Tan et al[78] |
M13 (pVIII) | pC89 with helper phage VASM13 | HBsAg28-39 | Mice (intradermal and intraperitoneal) no adjuvant added | MHC class I restricted HBsAg specific CTL response | Wan et al[40] | |
M13 (pIII) | pCANTAB5E with helper phage M13KO7 | PreS1 | NA | NA | Kok et al[41] | |
M13 (pIII) | pCANTAB5E with helper phage M13KO7 | HBcAg | Mice (intraperitoneal) incomplete Freund’s adjuvant | Anti-HBcAg antibody induced | Bahadir et al[42] | |
Identification of epitope or mimotope mimics | M13 nonapeptide library (pVIII) | (Selected from HBV-infected sera) | Φ13 CRTCAHPGEHA Φ17 CIPFYLSAPQC Φ30 CGPFFLSPTSC Φ41 CGPFFLAASVC | Mice (intraperitoneal) no adjuvant added | Anti-HBsAg antibody induced | Folgori et al[54] |
M13 (pVIII and pIII) | (Selected from HBV-infected sera) | Φ13, Φ35 (CVTCDTPPTY) ΦIII/17, ΦIII41 and ΦpIII/13 | Mice (intranasal/oral) cholera toxin as adjuvant | Anti-HBsAg antibody induced | Delmastro et al[56] | |
Phage-delivered DNA vaccine | λ | λ-gt11 | HBsAg gene | Mice (subcutaneous) | Anti-HBsAg antibody induced | Clark et al[59] |
λ | λ-gt11 | HBsAg gene | Rabbits (Intramuscular) | Anti-HBsAg antibody induced | Clark et al[61] |
NA: Not applicable; HBV: Hepatitis B virus; HBsAg: Hepatitis B surface antigen; MHC: Major histocompatibility complex; HBcAg: Hepatitis B core antigen; CTL: Cytotoxic T lymphocyte.